HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reginato, M. J. Articles by Lazar, M. A. Search for Related Content PubMed PubMed Citation Articles by Reginato, M. J. Articles by Lazar, M. A. Social Bookmarking                      What's this?

Volume 271, Number 45, Issue of November 8, 1996 pp. 28199-28205
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

DNA-independent and DNA-dependent Mechanisms Regulate the Differential Heterodimerization of the Isoforms of the Thyroid Hormone Receptor with Retinoid X Receptor

(Received for publication, May 8, 1996, and in revised form, July 2, 1996)

From the Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine, Genetics, Pharmacology, and Biochemistry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Thyroid hormone receptors (TRs) require heterodimerization with retinoid X receptor (RXR) for maximum DNA binding affinity. Interaction with RXR occurs via two dimerization interfaces, one in the DNA-binding domain and one in the C-terminal ``ninth heptad'' of the receptors. We studied the relative importance of these two dimerization domains in naturally occurring C-terminal TR variants. TR1 has a conserved ninth heptad and formed stable heterodimers with RXR in solution. TR1·RXR heterodimers bound similarly to direct repeat 4 (DR4) sites with different 5-flanking and spacer sequences. In contrast, TR2, which contains a highly divergent ninth heptad, did not interact with RXR in solution and bound as a heterodimer with RXR only to specific DR4 sequences in which the downstream half-site was the preferred octameric binding site of TR (TNAGGTCA). Although the ninth heptad of TR2 was insufficient for interaction with RXR off DNA, this region was required for DNA-dependent heterodimerization with RXR. TR3, another naturally occurring TR isoform whose ninth heptad differs from those of both TR1 and TR2, displayed intermediate behavior in heterodimerization with RXR. Thus, in the absence of a strong ninth heptad interaction an octameric downstream half-site allosterically promotes RXR heterodimerization with TR2. Differential dependence upon DNA-binding for heterodimerization with RXR may influence transcriptional regulation by TR isoforms.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K.-H. Lin, W.-J. Wang, Y.-H. Wu, and S.-Y. Cheng Activation of Antimetastatic Nm23-H1 Gene Expression by Estrogen and Its {alpha}-Receptor Endocrinology, February 1, 2002; 143(2): 467 - 475. [Abstract] [Full Text] [PDF]

				S. H. Jho, N. Radoja, M. J. Im, and M. Tomic-Canic Negative Response Elements in Keratin Genes Mediate Transcriptional Repression and the Cross-talk among Nuclear Receptors J. Biol. Chem., November 30, 2001; 276(49): 45914 - 45920. [Abstract] [Full Text] [PDF]

				L. Ng, A. Rusch, L. L. Amma, K. Nordstrom, L. C. Erway, B. Vennstrom, and D. Forrest Suppression of the deafness and thyroid dysfunction in Thrb-null mice by an independent mutation in the Thra thyroid hormone receptor {alpha} gene Hum. Mol. Genet., November 1, 2001; 10(23): 2701 - 2708. [Abstract] [Full Text] [PDF]

				P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]

				S. Göthe, Z. Wang, L. Ng, J. M. Kindblom, A. C. Barros, C. Ohlsson, B. Vennström, and D. Forrest Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation Genes & Dev., May 15, 1999; 13(10): 1329 - 1341. [Abstract] [Full Text]

				Y. Wu, Y.-Z. Yang, and R. J. Koenig Protein-Protein Interaction Domains and the Heterodimerization of Thyroid Hormone Receptor Variant {alpha}2 with Retinoid X Receptors Mol. Endocrinol., October 1, 1998; 12(10): 1542 - 1550. [Abstract] [Full Text]

				T. Tagami, P. Kopp, W. Johnson, O. K. Arseven, and J. L. Jameson The Thyroid Hormone Receptor Variant {alpha}2 Is a Weak Antagonist because It Is Deficient in Interactions with Nuclear Receptor Corepressors Endocrinology, May 1, 1998; 139(5): 2535 - 2544. [Abstract] [Full Text] [PDF]

				A. Farsetti, J. Lazar, M. Phyillaier, R. Lippoldt, A. Pontecorvi, and V. M. Nikodem Active Repression by Thyroid Hormone Receptor Splicing Variant {alpha}2 Requires Specific Regulatory Elements in the Context of Native Triiodothyronine-Regulated Gene Promoters Endocrinology, November 1, 1997; 138(11): 4705 - 4712. [Abstract] [Full Text] [PDF]

				I Zamir, J Zhang, and M A Lazar Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes & Dev., April 1, 1997; 11(7): 835 - 846. [Abstract] [PDF]

				Q. Shen and J. S. Subauste Dimerization Interfaces of v-ErbA Homodimers and Heterodimers with Retinoid X Receptor alpha J. Biol. Chem., December 22, 2000; 275(52): 41018 - 41027. [Abstract] [Full Text] [PDF]